Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREMIER: In-hospital Initiation of Sacubitril Valsartan for Acute Heart Failure
NCT05164653Phase 4Active, not recruiting
- Sponsor
- Saga University
- Start
- Dec 2021
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sacubitril + valsartan in heart failure (HF), sponsored by Saga University. Started Dec 2021; status: active, not recruiting.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT05164653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05164653.